Frankwinn Formulations Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 07-12-2024
- Paid Up Capital ₹ 2.00 M
as on 07-12-2024
- Company Age 28 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.22 M
as on 07-12-2024
- Satisfied Charges ₹ 2.00 M
as on 07-12-2024
- Revenue 8.66%
(FY 2019)
- Profit 11.80%
(FY 2019)
- Ebitda 17.79%
(FY 2019)
- Net Worth 17.23%
(FY 2019)
- Total Assets 28.81%
(FY 2019)
About Frankwinn Formulations
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹4.22 M. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Krishnam Sagi, Lakshmi Kalidindi, and Parvathi Sagi serve as directors at the Company.
- CIN/LLPIN
U85191AP1996PLC023727
- Company No.
023727
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 Apr 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Social Media-
Who are the key members and board of directors at Frankwinn Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnam Sagi  | Managing Director | 03-Sep-2009 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lakshmi Kalidindi | Whole-Time Director | 09-Apr-1996 | Current |
| Parvathi Sagi | Whole-Time Director | 15-Feb-2011 | Current |
Financial Performance of Frankwinn Formulations.
Frankwinn Formulations Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 8.66% increase. The company also saw a substantial improvement in profitability, with a 11.8% increase in profit. The company's net worth Soared by an impressive increase of 17.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Frankwinn Formulations?
In 2019, Frankwinn Formulations had a promoter holding of 49.10% and a public holding of 50.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Hyderabad Creation Date: 19 Oct 2015 | ₹0.72 M | Open |
State Bank Of Hyderabad Creation Date: 28 Mar 2015 | ₹3.50 M | Open |
Ing Vysya Bank Limited Creation Date: 08 Feb 2006 | ₹2.00 M | Satisfied |
How Many Employees Work at Frankwinn Formulations?
Unlock and access historical data on people associated with Frankwinn Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Frankwinn Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Frankwinn Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
